1: Reich N, Hölscher C. The neuroprotective effects of glucagon-like peptide 1
in Alzheimer's and Parkinson's disease: An in-depth review. Front Neurosci. 2022
Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. PMID: 36117625; PMCID:
PMC9475012.

2: Coles M, Steiner-Lim GZ, Karl T. Therapeutic properties of multi-cannabinoid
treatment strategies for Alzheimer's disease. Front Neurosci. 2022 Sep
2;16:962922. doi: 10.3389/fnins.2022.962922. PMID: 36117622; PMCID: PMC9479694.

3: Adcock KS, Lawlor B, Robertson IH, Vanneste S. Diminishing accelerated long-
term forgetting in mild cognitive impairment: Study protocol for a prospective,
double-blind, placebo-controlled, randomized controlled trial. Contemp Clin
Trials Commun. 2022 Sep 2;30:100989. doi: 10.1016/j.conctc.2022.100989. PMID:
36117569; PMCID: PMC9478352.

4: Shan G, Ritter A, Miller J, Bernick C. Effects of dose change on the success
of clinical trials. Contemp Clin Trials Commun. 2022 Sep 5;30:100988. doi:
10.1016/j.conctc.2022.100988. PMID: 36117568; PMCID: PMC9478360.

5: Takahashi J, Ueta Y, Yamada D, Sasaki-Hamada S, Iwai T, Akita T, Yamashita C,
Saitoh A, Oka JI. Intracerebroventricular administration of oxytocin and
intranasal administration of the oxytocin derivative improve β-amyloid peptide
(25-35)-induced memory impairment in mice. Neuropsychopharmacol Rep. 2022 Sep
19. doi: 10.1002/npr2.12292. Epub ahead of print. PMID: 36117475.

6: Mathioudakis L, Dimovasili C, Bourbouli M, Latsoudis H, Kokosali E, Gouna G,
Vogiatzi E, Basta M, Kapetanaki S, Panagiotakis S, Kanterakis A, Boumpas D,
Lionis C, Plaitakis A, Simos P, Vgontzas A, Kafetzopoulos D, Zaganas I. Study of
Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan
Aging Cohort. Neurobiol Aging. 2022 Jul 11:S0197-4580(22)00146-4. doi:
10.1016/j.neurobiolaging.2022.07.002. Epub ahead of print. PMID: 36117051.

7: Mazzo F, Butnaru I, Grubisha O, Ficulle E, Sanger H, Fitzgerald G, Pan F,
Pasqui F, Murray T, Monn J, Li X, Hutton M, Bose S, Schiavo G, Sher E.
Metabotropic glutamate receptors modulate exocytotic tau release and
propagation. J Pharmacol Exp Ther. 2022 Sep 18:JPET-AR-2022-001307. doi:
10.1124/jpet.122.001307. Epub ahead of print. PMID: 36116796.

8: Wang J, Li Z, Pan M, Fiaz M, Hao Y, Yan Y, Sun L, Yan F. Ultrasound-mediated
blood-brain barrier opening: An effective drug delivery system for theranostics
of brain diseases. Adv Drug Deliv Rev. 2022 Sep 15;190:114539. doi:
10.1016/j.addr.2022.114539. Epub ahead of print. PMID: 36116720.

9: Falangola MF, Nie X, Voltin J, Ward R, Dhiman S, Nietert PJ, Jensen JH. Brain
microstructure abnormalities in the 3xTg-AD mouse - A diffusion MRI and
morphology correlation study. Magn Reson Imaging. 2022 Sep 16;94:48-55. doi:
10.1016/j.mri.2022.09.002. Epub ahead of print. PMID: 36116712.

10: Zhai Z, Xie D, Qin T, Zhong Y, Xu Y, Sun T. Effect and Mechanism of
Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer's
Disease: A Systematic review and Meta-analysis. Neuroscience. 2022 Sep
15:S0306-4522(22)00466-3. doi: 10.1016/j.neuroscience.2022.09.012. Epub ahead of
print. PMID: 36116555.

11: Elamin T, Santos NP, Briza P, Brandstetter H, Dall E. Structural and
functional studies of legumain-mycocypin complexes revealed a competitive,
exosite-regulated mode of interaction. J Biol Chem. 2022 Sep 15:102502. doi:
10.1016/j.jbc.2022.102502. Epub ahead of print. PMID: 36116553.

12: Trevenen ML, Heyworth J, Almeida OP, Yeap BB, Hankey GJ, Golledge J,
Etherton-Beer C, Robinson S, Nieuwenhuijsen MJ, Flicker L. Ambient air pollution
and risk of incident dementia in older men living in a region with relatively
low concentrations of pollutants: The health in Men study. Environ Res. 2022 Sep
15:114349. doi: 10.1016/j.envres.2022.114349. Epub ahead of print. PMID:
36116491.

13: Verhagen C, Janssen J, Minderhoud CA, van den Berg E, Wanner C, Passera A,
Johansen OE, Biessels GJ. Chronic kidney disease and cognitive decline in
patients with type 2 diabetes at elevated cardiovascular risk. J Diabetes
Complications. 2022 Oct;36(10):108303. doi: 10.1016/j.jdiacomp.2022.108303. Epub
2022 Aug 31. PMID: 36116359.

14: Li A, Yan Y, Qiu J, Yan G, Zhao P, Li M, Ji Y, Wang G, Meng F, Li Y, Metcalf
JS, Banack SA. Putative biosynthesis mechanism of the neurotoxin β-N-
methylamino-L-alanine in marine diatoms based on a transcriptomics approach. J
Hazard Mater. 2022 Sep 10;441:129953. doi: 10.1016/j.jhazmat.2022.129953. Epub
ahead of print. PMID: 36116313.

15: de Souza LC, Bertoux M, Radakovic R, Hornberger M, Mariano LI, Resende EPF,
Quesque F, Guimarães HC, Gambogi LB, Tumas V, Camargos ST, Cardoso FEC, Teixeira
AL, Caramelli P. I'm looking through you: Mentalizing in frontotemporal dementia
and progressive supranuclear palsy. Cortex. 2022 Oct;155:373-389. doi:
10.1016/j.cortex.2022.07.015. Epub 2022 Aug 27. PMID: 36116296.

16: Degrush E, Shazeeb MS, Drachman D, Vardar Z, Lindsay C, Gounis MJ, Henninger
N. Cumulative effect of simvastatin, L-arginine, and tetrahydrobiopterin on
cerebral blood flow and cognitive function in Alzheimer's disease. Alzheimers
Res Ther. 2022 Sep 17;14(1):134. doi: 10.1186/s13195-022-01076-7. PMID:
36115980; PMCID: PMC9482313.

17: Arighi A, Arcaro M, Fumagalli GG, Carandini T, Pietroboni AM, Sacchi L,
Fenoglio C, Serpente M, Sorrentino F, Isgrò G, Turkheimer F, Scarpini E,
Galimberti D. Aquaporin-4 cerebrospinal fluid levels are higher in
neurodegenerative dementia: looking at glymphatic system dysregulation.
Alzheimers Res Ther. 2022 Sep 17;14(1):135. doi: 10.1186/s13195-022-01077-6.
PMID: 36115967; PMCID: PMC9482276.

18: Österlund N, Vosselman T, Leppert A, Gräslund A, Jörnvall H, Ilag LL,
Marklund EG, Elofsson A, Johansson J, Sahin C, Landreh M. Mass spectrometry and
machine learning reveal determinants of client recognition by anti-amyloid
chaperones. Mol Cell Proteomics. 2022 Sep 14:100413. doi:
10.1016/j.mcpro.2022.100413. Epub ahead of print. PMID: 36115577.

19: Sarkar S. Microglial ion channels: Key players in non-cell autonomous
neurodegeneration. Neurobiol Dis. 2022 Sep 14;174:105861. doi:
10.1016/j.nbd.2022.105861. Epub ahead of print. PMID: 36115552.

20: Hunt NJ, Wahl D, Westwood LJ, Lockwood GP, Le Couteur DG, Cogger VC.
Targeting the liver in dementia and cognitive impairment: Dietary macronutrients
and diabetic therapeutics. Adv Drug Deliv Rev. 2022 Sep 14;190:114537. doi:
10.1016/j.addr.2022.114537. Epub ahead of print. PMID: 36115494.

21: Lv SY, He S, Ling XL, Wang YQ, Huang C, Long JR, Wang JQ, Qin Y, Wei H, Yu
CY. Review of lipoic acid: From a clinical therapeutic agent to various emerging
biomaterials. Int J Pharm. 2022 Sep 14;627:122201. doi:
10.1016/j.ijpharm.2022.122201. Epub ahead of print. PMID: 36115465.

22: Kenyaga JM, Cheng Q, Qiang W. Early-Stage β-Amyloid-Membrane Interactions
Modulate Lipid Dynamics and Influence Structural Interfaces and Fibrillation. J
Biol Chem. 2022 Sep 14:102491. doi: 10.1016/j.jbc.2022.102491. Epub ahead of
print. PMID: 36115457.

23: Jack CR Jr. Advances in Alzheimer's disease research over the past two
decades. Lancet Neurol. 2022 Oct;21(10):866-869. doi:
10.1016/S1474-4422(22)00298-8. PMID: 36115352.

24: Fevga C, Ferraro F, Breedveld GJ, Savant Sankhla C, Bonifati V. Segmental
dystonia as the prominent phenotype resulting from a MICU1 splice variant in a
new Indian case. Parkinsonism Relat Disord. 2022 Sep 9;103:141-143. doi:
10.1016/j.parkreldis.2022.08.031. Epub ahead of print. PMID: 36115200.

25: Peng Z, Duggan MR, Dark HE, Daya GN, An Y, Davatzikos C, Erus G, Lewis A,
Moghekar AR, Walker KA. Association of liver disease with brain volume loss,
cognitive decline, and plasma neurodegenerative disease biomarkers. Neurobiol
Aging. 2022 Aug 17;120:34-42. doi: 10.1016/j.neurobiolaging.2022.08.004. Epub
ahead of print. PMID: 36115133.

26: Ouyang J, Zhao Q, Adeli E, Zaharchuk G, Pohl KM. Self-supervised learning of
neighborhood embedding for longitudinal MRI. Med Image Anal. 2022 Aug
27;82:102571. doi: 10.1016/j.media.2022.102571. Epub ahead of print. PMID:
36115098.

27: Schubert CR, Fischer ME, Pinto AA, Paulsen AJ, Chen Y, Huang GH, Klein BEK,
Tsai MY, Merten N, Cruickshanks KJ. Inflammation, metabolic dysregulation and
environmental neurotoxins and risk of cognitive decline and impairment in
midlife. Neurol Sci. 2022 Sep 17. doi: 10.1007/s10072-022-06386-0. Epub ahead of
print. PMID: 36114981.

28: Tábuas-Pereira M, Guerreiro R, Kun-Rodrigues C, Almeida MR, Brás J, Santana
I. Whole-exome sequencing reveals PSEN1 and ATP7B combined variants as a
possible cause of early-onset Lewy body dementia: a case study of genotype-
phenotype correlation. Neurogenetics. 2022 Sep 17. doi:
10.1007/s10048-022-00699-0. Epub ahead of print. PMID: 36114914.

29: Zhang H, Xie X, Shi J, Zhao Q, Luo D, Hao J, Zhou Y, Han G, Pang X. 3, 14,
19-Triacetyl Andrographolide alleviates the cognitive dysfunction of 3 × Tg-AD
mice by inducing initiation and promoting degradation process of autophagy.
Phytother Res. 2022 Sep 17. doi: 10.1002/ptr.7619. Epub ahead of print. PMID:
36114804.

30: Raket LL. Progression models for repeated measures: Estimating novel
treatment effects in progressive diseases. Stat Med. 2022 Sep 17. doi:
10.1002/sim.9581. Epub ahead of print. PMID: 36114798.

31: Li L, Miao J, Chu D, Jin N, Tung YC, Dai CL, Hu W, Gong CX, Iqbal K, Liu F.
Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic
tau to seed tau aggregation. CNS Neurosci Ther. 2022 Sep 17. doi:
10.1111/cns.13970. Epub ahead of print. PMID: 36114722.

32: Iseki C, Takahashi Y, Adachi M, Igari R, Sato H, Koyama S, Ishizawa K, Ohta
Y, Kato T. Prevalence and development of idiopathic normal pressure
hydrocephalus: A 16-year longitudinal study in Japan. Acta Neurol Scand. 2022
Sep 16. doi: 10.1111/ane.13710. Epub ahead of print. PMID: 36114711.

33: Veldwijk-Rouwenhorst AE, Zuidema SU, Smalbrugge M, Persoon A, Koopmans RTCM,
Gerritsen DL. Losing hope or keep searching for a golden solution: an in-depth
exploration of experiences with extreme challenging behavior in nursing home
residents with dementia. BMC Geriatr. 2022 Sep 16;22(1):758. doi:
10.1186/s12877-022-03438-0. PMID: 36114482; PMCID: PMC9479311.

34: Bramato G, Barone R, Barulli MR, Zecca C, Tortelli R, Filardi M, Logroscino
G. Sarcopenia screening in elderly with Alzheimer's disease: performances of the
SARC-F-3 and MSRA-5 questionnaires. BMC Geriatr. 2022 Sep 17;22(1):761. doi:
10.1186/s12877-022-03441-5. PMID: 36114480; PMCID: PMC9482268.

35: Rye I, Vik A, Kocinski M, Lundervold AS, Lundervold AJ. Predicting
conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment
using clinically transferable features. Sci Rep. 2022 Sep 16;12(1):15566. doi:
10.1038/s41598-022-18805-5. PMID: 36114257; PMCID: PMC9481567.

36: Peña-Bautista C, Tarazona-Sánchez A, Braza-Boils A, Balaguer A, Ferré-
González L, Cañada-Martínez AJ, Baquero M, Cháfer-Pericás C. Plasma microRNAs as
potential biomarkers in early Alzheimer disease expression. Sci Rep. 2022 Sep
16;12(1):15589. doi: 10.1038/s41598-022-19862-6. PMID: 36114255; PMCID:
PMC9481579.

37: Maurus I, Roell L, Keeser D, Papazov B, Papazova I, Lembeck M, Roeh A,
Wagner E, Hirjak D, Malchow B, Ertl-Wagner B, Stoecklein S, Hasan A, Schmitt A,
Meyer-Lindenberg A, Falkai P. Fitness is positively associated with hippocampal
formation subfield volumes in schizophrenia: a multiparametric magnetic
resonance imaging study. Transl Psychiatry. 2022 Sep 16;12(1):388. doi:
10.1038/s41398-022-02155-x. PMID: 36114184; PMCID: PMC9481539.

38: Seidler PM, Murray KA, Boyer DR, Ge P, Sawaya MR, Hu CJ, Cheng X, Abskharon
R, Pan H, DeTure MA, Williams CK, Dickson DW, Vinters HV, Eisenberg DS.
Structure-based discovery of small molecules that disaggregate Alzheimer's
disease tissue derived tau fibrils in vitro. Nat Commun. 2022 Sep 16;13(1):5451.
doi: 10.1038/s41467-022-32951-4. PMID: 36114178; PMCID: PMC9481533.

39: Paik H, Lee J, Jeong CS, Park JS, Lee JH, Rappoport N, Kim Y, Sohn HY, Jo C,
Kim J, Cho SB. Identification of a pleiotropic effect of ADIPOQ on cardiac
dysfunction and Alzheimer's disease based on genetic evidence and health care
records. Transl Psychiatry. 2022 Sep 16;12(1):389. doi:
10.1038/s41398-022-02144-0. PMID: 36114174; PMCID: PMC9481623.

40: White RS, Barber JM, Harp JP, Jicha GA. Examining the Effects of Formal
Education Level on the Montreal Cognitive Assessment. J Am Board Fam Med. 2022
Sep 16:jabfm.2022.AP.220093. doi: 10.3122/jabfm.2022.AP.220093. Epub ahead of
print. PMID: 36113992.

41: Frank D, Garo-Pascual M, Velasquez PAR, Frades B, Peled N, Zhang L, Strange
BA. Brain structure and episodic learning rate in cognitively healthy ageing.
Neuroimage. 2022 Sep 13;263:119630. doi: 10.1016/j.neuroimage.2022.119630. Epub
ahead of print. PMID: 36113738.

42: Xu C, Zhang J, Zhou Q, Wang J, Liu C, Tian Y, Huang D, Ye H, Jin Y. Exposure
to a real traffic environment impairs brain cognition in aged mice. Environ Res.
2022 Sep 14;215(Pt 1):114181. doi: 10.1016/j.envres.2022.114181. Epub ahead of
print. PMID: 36113572.

43: Pridmore W. Aducanumab for Alzheimer's disease: Observations and
opportunities. Australas Psychiatry. 2022 Sep 13:10398562221121215. doi:
10.1177/10398562221121215. Epub ahead of print. PMID: 36113474.

44: Chen CY, Chung CH, Chien WC, Chen HC. The Association Between
Dextromethorphan Use and the Risk of Dementia. Am J Alzheimers Dis Other Demen.
2022 Jan-Dec;37:15333175221124952. doi: 10.1177/15333175221124952. PMID:
36113413.

45: Jarosova R, Niyangoda SS, Hettiarachchi P, Johnson MA. Impaired Dopamine
Release and Latent Learning in Alzheimer's Disease Model Zebrafish. ACS Chem
Neurosci. 2022 Sep 16. doi: 10.1021/acschemneuro.2c00484. Epub ahead of print.
PMID: 36113115.

46: Li Q, Wang X, Wang ZH, Lin Z, Yang J, Chen J, Wang R, Ye W, Li Y, Wu Y, Xuan
A. Changes in dendritic complexity and spine morphology following BCG
immunization in APP/PS1 mice. Hum Vaccin Immunother. 2022 Sep 16:2121568. doi:
10.1080/21645515.2022.2121568. Epub ahead of print. PMID: 36113067.

47: Conte FP, Okely JA, Hamilton OK, Corley J, Page D, Redmond P, Taylor AM,
Russ TC, Deary IJ, Cox SR. Cognitive Change Before Old Age (11 to 70) Predicts
Cognitive Change During Old Age (70 to 82). Psychol Sci. 2022 Sep
15:9567976221100264. doi: 10.1177/09567976221100264. Epub ahead of print. PMID:
36113037.

48: Wu XJ, Shu QQ, Wang B, Dong L, Hao B. Acetoacetate Improves Memory in
Alzheimer's Mice via Promoting Brain-Derived Neurotrophic Factor and Inhibiting
Inflammation. Am J Alzheimers Dis Other Demen. 2022 Jan-
Dec;37:15333175221124949. doi: 10.1177/15333175221124949. PMID: 36113018.

49: Richards KC, Radhakrishnan K, Britt KC, Vanags-Louredo A, Park E, Gooneratne
NS, Fry L. "Please Don't Forget Us": A Descriptive Qualitative Study of
Caregivers of Older Adults With Alzheimer's Disease and Related Dementias During
the COVID-19 Pandemic. Res Gerontol Nurs. 2022 Sep-Oct;15(5):217-228. doi:
10.3928/19404921-20220829-01. Epub 2022 Sep 1. PMID: 36113012.

50: Salleh WMNHW, Ghani NA, Abdel-Aal AM. Chemical composition and
anticholinesterase activity of <i>Lepisanthes rubiginosa</i> (Roxb.) Leenh.
essential oil. Z Naturforsch C J Biosci. 2022 Sep 19. doi:
10.1515/znc-2022-0105. Epub ahead of print. PMID: 36112782.

51: Banoo R, Nuthakki VK, Abdullaha M, Sharma M, Bharate SB. Blood-brain barrier
permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual
cholinesterase inhibitors. Drug Dev Res. 2022 Sep 16. doi: 10.1002/ddr.21997.
Epub ahead of print. PMID: 36112736.

52: Omidfar F, Gheybi F, Davoodi J, Amirinejad M, Badiee A. Nanophytosomes of
Hesperidin and of Hesperetin: Preparation, characterization and in vivo
evaluation. Biotechnol Appl Biochem. 2022 Sep 16. doi: 10.1002/bab.2404. Epub
ahead of print. PMID: 36112716.

53: Han X, Wang X, Wang C, Wang P, Han X, Zhao M, Han Q, Jiang Z, Mao M, Chen S,
Welmer AK, Launer LJ, Wang Y, Du Y, Qiu C. Accelerometer-assessed sedentary
behaviour among Chinese rural older adults: Patterns and associations with
physical function. J Sports Sci. 2022 Sep 16:1-10. doi:
10.1080/02640414.2022.2122321. Epub ahead of print. PMID: 36112669.

54: Rekers S, Niedeggen M. Intuitive assessment of spatial navigation beyond
episodic memory: Feasibility and proof of concept in middle-aged and elderly
individuals. PLoS One. 2022 Sep 16;17(9):e0270563. doi:
10.1371/journal.pone.0270563. PMID: 36112627; PMCID: PMC9481041.

55: Malik AK, Tanveer M. Graph embedded ensemble deep randomized network for
diagnosis of Alzheimer's disease. IEEE/ACM Trans Comput Biol Bioinform. 2022 Sep
16;PP. doi: 10.1109/TCBB.2022.3202707. Epub ahead of print. PMID: 36112566.

56: Witek JA, Brooks AF, Scott PJH. Classics in Neuroimaging: Untangling the
Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
ACS Chem Neurosci. 2022 Sep 16. doi: 10.1021/acschemneuro.2c00519. Epub ahead of
print. PMID: 36112411.

57: Klein AZ, Magge A, O'Connor K, Gonzalez-Hernandez G. Automatically
Identifying Twitter Users for Interventions to Support Dementia Family
Caregivers: Annotated Data Set and Benchmark Classification Models. JMIR Aging.
2022 Sep 16;5(3):e39547. doi: 10.2196/39547. PMID: 36112408; PMCID: PMC9526111.

58: Wang Z, Zhang Y, Feng W, Pang Y, Chen S, Ding S, Chen Y, Sheng C, Marshall
C, Shi J, Xiao M. Miconazole Promotes Cooperative Ability of a Mouse Model of
Alzheimer's Disease. Int J Neuropsychopharmacol. 2022 Sep 16:pyac061. doi:
10.1093/ijnp/pyac061. Epub ahead of print. PMID: 36112386.

59: Liu Y, Song Y, Johnson FU, Lei L, Choi SE, Antonucci TC, Robinson-Lane SG.
Characteristics and Predictors of Sleep among Spousal Care Dyads Living with
Chronic Conditions. J Gerontol B Psychol Sci Soc Sci. 2022 Sep 16:gbac096. doi:
10.1093/geronb/gbac096. Epub ahead of print. PMID: 36112385.

60: Kaufmann E, Rojczyk P, Sydnor VJ, Guenette JP, Tripodis Y, Kaufmann D,
Umminger L, Seitz-Holland J, Sollmann N, Rathi Y, Bouix S, Fortier CB, Salat D,
Pasternak O, Hinds SR, Milberg WP, McGlinchey RE, Shenton ME, Koerte IK.
Association of War Zone-Related Stress With Alterations in Limbic Gray Matter
Microstructure. JAMA Netw Open. 2022 Sep 1;5(9):e2231891. doi:
10.1001/jamanetworkopen.2022.31891. PMID: 36112375; PMCID: PMC9482063.

61: Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Le Voyer T, Bizien L,
Manry J, Rosain J, Philippot Q, Goavec K, Padey B, Cupic A, Laurent E, Saker K,
Vanker M, Särekannu K; COVID Human Genetic Effort; Etablissement Français du
Sang Study Group; Constances Cohort; 3C-Dijon Study; Cerba HealthCare Group;
Lyon Antigrippe Working Group; REIPI INF Working Group, García-Salum T, Ferres
M, Le Corre N, Sánchez-Céspedes J, Balsera-Manzanero M, Carratala J, Retamar-
Gentil P, Abelenda-Alonso G, Valiente A, Tiberghien P, Zins M, Debette S, Meyts
I, Haerynck F, Castagnoli R, Notarangelo LD, Gonzalez-Granado LI, Dominguez-
Pinilla N, Andreakos E, Triantafyllia V, Rodríguez-Gallego C, Solé-Violán J,
Ruiz-Hernandez JJ, Rodríguez de Castro F, Ferreres J, Briones M, Wauters J,
Vanderbeke L, Feys S, Kuo CY, Lei WT, Ku CL, Tal G, Etzioni A, Hanna S, Fournet
T, Casalegno JS, Queromes G, Argaud L, Javouhey E, Rosa-Calatrava M, Cordero E,
Aydillo T, Medina RA, Kisand K, Puel A, Jouanguy E, Abel L, Cobat A, Trouillet-
Assant S, García-Sastre A, Casanova JL. Autoantibodies against type I IFNs in
patients with critical influenza pneumonia. J Exp Med. 2022 Nov
7;219(11):e20220514. doi: 10.1084/jem.20220514. Epub 2022 Sep 16. PMID:
36112363; PMCID: PMC9485705.

62: Guhl M, Mercier F, Hofmann C, Sharan S, Donnelly M, Feng K, Sun W, Sun G,
Grosser S, Zhao L, Fang L, Mentré F, Comets E, Bertrand J. Impact of model
misspecification on model-based tests in PK studies with parallel design: real
case and simulation studies. J Pharmacokinet Pharmacodyn. 2022
Oct;49(5):557-577. doi: 10.1007/s10928-022-09821-z. Epub 2022 Sep 16. PMID:
36112338; PMCID: PMC9483500.

63: Brockmueller A, Mahmoudi N, Movaeni AK, Mueller AL, Kajbafzadeh AM,
Shakibaei M, Zolbin MM. Stem Cells and Natural Agents in the Management of
Neurodegenerative Diseases: A New Approach. Neurochem Res. 2022 Sep 16. doi:
10.1007/s11064-022-03746-2. Epub ahead of print. PMID: 36112254.

64: Ichimata S, Martinez-Valbuena I, Forrest SL, Kovacs GG. Expanding the
spectrum of amyloid-β plaque pathology: the Down syndrome associated 'bird-nest
plaque'. Acta Neuropathol. 2022 Sep 16. doi: 10.1007/s00401-022-02500-w. Epub
ahead of print. PMID: 36112224.

65: Kim B, Suh E, Nguyen AT, Prokop S, Mikytuck B, Olatunji OA, Robinson JL,
Grossman M, Phillips JS, Irwin DJ, Mechanic-Hamilton D, Wolk DA, Trojanowski JQ,
McMillan CT, Van Deerlin VM, Lee EB. TREM2 risk variants are associated with
atypical Alzheimer's disease. Acta Neuropathol. 2022 Sep 16. doi:
10.1007/s00401-022-02495-4. Epub ahead of print. PMID: 36112222.

66: Venkatesan K. Anti-amnesic and anti-cholinesterase activities of α-asarone
against scopolamine-induced memory impairments in rats. Eur Rev Med Pharmacol
Sci. 2022 Sep;26(17):6344-6350. doi: 10.26355/eurrev_202209_29660. PMID:
36111936.

67: Lee H, Choi SH, Anzai Y. Glymphatic MRI techniques in sleep and
neurodegenerative diseases. Curr Opin Pulm Med. 2022 Sep 19. doi:
10.1097/MCP.0000000000000923. Epub ahead of print. PMID: 36111851.

68: Nguyen LT, Prophater LE, Fazio S, Hülür G, Tate R, Sherwin K, Shatzer J,
Peterson LJ, Haley WE. Project VITAL at Home: Impact of Technology on Loneliness
and Well-Being of Family Caregivers of People with Dementia. Clin Gerontol. 2022
Sep 16:1-12. doi: 10.1080/07317115.2022.2123726. Epub ahead of print. PMID:
36111824.

69: Dunlop SR, Ayala I, Spencer C, Flanagan ME, Mesulam MM, Gefen T, Geula C.
Resistance of Basal Forebrain Cholinergic Neurons to TDP-43 Proteinopathy in
Primary Progressive Aphasia. J Neuropathol Exp Neurol. 2022 Sep 16:nlac079. doi:
10.1093/jnen/nlac079. Epub ahead of print. PMID: 36111818.

70: Granot-Hershkovitz E, He S, Bressler J, Yu B, Tarraf W, Rebholz CM, Cai J,
Chan Q, Garcia TP, Mosley T, Kristal BS, DeCarli C, Fornage M, Chen GC, Qi Q,
Kaplan R, González HM, Sofer T. Plasma metabolites associated with cognitive
function across race/ethnicities affirming the importance of healthy nutrition.
Alzheimers Dement. 2022 Sep 16. doi: 10.1002/alz.12786. Epub ahead of print.
PMID: 36111689.

71: Välimäki NN, Bakreen A, Häkli S, Dhungana H, Keuters MH, Dunlop Y, Koskuvi
M, Keksa-Goldsteine V, Oksanen M, Jäntti H, Lehtonen Š, Malm T, Koistinaho J,
Jolkkonen J. Astrocyte Progenitors Derived From Patients With Alzheimer Disease
Do Not Impair Stroke Recovery in Mice. Stroke. 2022 Oct;53(10):3192-3201. doi:
10.1161/STROKEAHA.122.039700. Epub 2022 Sep 16. PMID: 36111544.

72: Lee YM, Teoh DE, Yeung K, Liou YC. The kingdom of the prolyl-isomerase Pin1:
The structural and functional convergence and divergence of Pin1. Front Cell Dev
Biol. 2022 Aug 30;10:956071. doi: 10.3389/fcell.2022.956071. PMID: 36111342;
PMCID: PMC9468764.

73: Swann OJ, Turner M, Heslegrave A, Zetterberg H. Fluid biomarkers and risk of
neurodegenerative disease in retired athletes with multiple concussions: results
from the International Concussion and Head Injury Research Foundation Brain
health in Retired athletes Study of Ageing and Impact-Related Neurodegenerative
Disease (ICHIRF-BRAIN study). BMJ Open Sport Exerc Med. 2022 Sep 1;8(3):e001327.
doi: 10.1136/bmjsem-2022-001327. PMID: 36111130; PMCID: PMC9438045.

74: Atkins KJ, Evered L, Scott DA, Fowler C, Masters CL, Silbert B.
Cerebrospinal fluid sampling for research of Alzheimer's disease and other
neurodegenerative diseases when lumbar punctures are performed by anaesthetists.
BMJ Neurol Open. 2022 Sep 5;4(2):e000335. doi: 10.1136/bmjno-2022-000335. PMID:
36110925; PMCID: PMC9445826.

75: Pinho-Gomes AC, Gong J, Harris K, Woodward M, Carcel C. Dementia clinical
trials over the past decade: are women fairly represented? BMJ Neurol Open. 2022
Sep 5;4(2):e000261. doi: 10.1136/bmjno-2021-000261. PMID: 36110923; PMCID:
PMC9445798.

76: Khodayi-Shahrak M, Khalaj-Kondori M, Hosseinpour Feizi MA, Talebi M.
Insights into the mechanisms of non-coding RNAs' implication in the pathogenesis
of Alzheimer's disease. EXCLI J. 2022 Jun 30;21:921-940. doi:
10.17179/excli2022-5006. PMID: 36110561; PMCID: PMC9441681.

77: Liu Q, Zhang J, Xiao C, Su D, Li L, Yang C, Zhao Z, Jiang W, You Z, Zhou T.
Akebia saponin D protects hippocampal neurogenesis from microglia-mediated
inflammation and ameliorates depressive-like behaviors and cognitive impairment
in mice through the PI3K-Akt pathway. Front Pharmacol. 2022 Aug 30;13:927419.
doi: 10.3389/fphar.2022.927419. PMID: 36110522; PMCID: PMC9468712.

78: Lamsal Lamichhane S, Ramesh V, Opara CO, Khan FY, Kabiraj G, Kauser H,
Palakeel JJ, Ali M, Chaduvula P, Chhabra S, Mohammed L. Treatment Modalities for
Dementia in Down's Syndrome: A Literature Review. Cureus. 2022 Aug
11;14(8):e27881. doi: 10.7759/cureus.27881. PMID: 36110433; PMCID: PMC9462651.

79: Cody KA, Koscik RL, Erickson CM, Berman SE, Jonaitis EM, Williams VJ,
Mueller KD, Christian BT, Chin NA, Clark LR, Betthauser TJ, Johnson SC.
Associations of the Lifestyle for Brain Health index with longitudinal cognition
and brain amyloid beta in clinically unimpaired older adults: Findings from the
Wisconsin Registry for Alzheimer's Prevention. Alzheimers Dement (Amst). 2022
Sep 11;14(1):e12351. doi: 10.1002/dad2.12351. PMID: 36110432; PMCID: PMC9464997.

80: Zhao K, Zhang H, Wu Y, Liu J, Li X, Lin J. Integrated analysis and
identification of hub genes as novel biomarkers for Alzheimer's disease. Front
Aging Neurosci. 2022 Aug 30;14:901972. doi: 10.3389/fnagi.2022.901972. PMID:
36110430; PMCID: PMC9468260.

81: Manzali SB, Yu E, Ravona-Springer R, Livny A, Golan S, Ouyang Y, Lesman-
Segev O, Liu L, Ganmore I, Alkelai A, Gan-Or Z, Lin HM, Heymann A, Schnaider
Beeri M, Greenbaum L. Alzheimer's Disease Polygenic Risk Score Is Not Associated
With Cognitive Decline Among Older Adults With Type 2 Diabetes. Front Aging
Neurosci. 2022 Aug 30;14:853695. doi: 10.3389/fnagi.2022.853695. PMID: 36110429;
PMCID: PMC9468264.

82: Marsili L, Canevelli M, Rodriguez-Porcel F. Editorial: The many faces of
brain aging. Front Aging Neurosci. 2022 Aug 30;14:1018238. doi:
10.3389/fnagi.2022.1018238. PMID: 36110427; PMCID: PMC9468894.

83: Huang LC, Chen MH, Chuu CP, Li KY, Hour TC, Yang YH. Plasma biomarkers and
their correlation in adult children of parents with Alzheimer's disease. Front
Aging Neurosci. 2022 Aug 30;14:977515. doi: 10.3389/fnagi.2022.977515. PMID:
36110426; PMCID: PMC9468332.

84: Qiao J, Wang R, Liu H, Xu G, Wang Z. Brain disorder prediction with dynamic
multivariate spatio-temporal features: Application to Alzheimer's disease and
autism spectrum disorder. Front Aging Neurosci. 2022 Aug 30;14:912895. doi:
10.3389/fnagi.2022.912895. PMID: 36110425; PMCID: PMC9468323.

85: Llorente-Ovejero A, Bengoetxea de Tena I, Martínez-Gardeazabal J, Moreno-
Rodríguez M, Lombardero L, Manuel I, Rodríguez-Puertas R. Cannabinoid Receptors
and Glial Response Following a Basal Forebrain Cholinergic Lesion. ACS Pharmacol
Transl Sci. 2022 Aug 4;5(9):791-802. doi: 10.1021/acsptsci.2c00069. PMID:
36110372; PMCID: PMC9469185.

86: Euler MJ, Duff K, King JB, Hoffman JM. Recall and recognition subtests of
the repeatable battery for the assessment of neuropsychological status and their
relationship to biomarkers of Alzheimer's disease. Neuropsychol Dev Cogn B Aging
Neuropsychol Cogn. 2022 Sep 15:1-18. doi: 10.1080/13825585.2022.2124229. Epub
ahead of print. PMID: 36110031.

87: Li L, Yu X, Sheng C, Jiang X, Zhang Q, Han Y, Jiang J. A review of brain
imaging biomarker genomics in Alzheimer's disease: implementation and
perspectives. Transl Neurodegener. 2022 Sep 15;11(1):42. doi:
10.1186/s40035-022-00315-z. PMID: 36109823; PMCID: PMC9476275.

88: Park H, Shin J, Kim Y, Saito T, Saido TC, Kim J.
CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain
pathology in a mouse model of Alzheimer's disease. Transl Neurodegener. 2022 Sep
15;11(1):41. doi: 10.1186/s40035-022-00314-0. PMID: 36109806; PMCID: PMC9476342.

89: Mank A, Rijnhart JJM, van Maurik IS, Jönsson L, Handels R, Bakker ED,
Teunissen CE, van Berckel BNM, van Harten AC, Berkhof J, van der Flier WM. A
longitudinal study on quality of life along the spectrum of Alzheimer's disease.
Alzheimers Res Ther. 2022 Sep 15;14(1):132. doi: 10.1186/s13195-022-01075-8.
PMID: 36109800; PMCID: PMC9476356.

90: C Silva T, Zhang W, Young JI, Gomez L, Schmidt MA, Varma A, Chen XS, Martin
ER, Wang L. Distinct sex-specific DNA methylation differences in Alzheimer's
disease. Alzheimers Res Ther. 2022 Sep 15;14(1):133. doi:
10.1186/s13195-022-01070-z. PMID: 36109771; PMCID: PMC9479371.

91: Marziliano A, Burns E, Pampanini T, Tom J, Ardito S, Ilyas A, Carney MT,
Diefenbach MA, Makhnevich A, Sinvani L. The psychosocial health, experiences and
needs of older adults and care partners during the first surge of the COVID-19
pandemic: a mixed-methods study. BMC Geriatr. 2022 Sep 15;22(1):752. doi:
10.1186/s12877-022-03427-3. PMID: 36109714; PMCID: PMC9476311.

92: El Kantar S, Yassin A, Nehmeh B, Labaki L, Mitri S, Naser Aldine F, Hirko A,
Caballero S, Monck E, Garcia-Maruniak A, Akoury E. Deciphering the therapeutical
potentials of rosmarinic acid. Sci Rep. 2022 Sep 15;12(1):15489. doi:
10.1038/s41598-022-19735-y. PMID: 36109609; PMCID: PMC9476430.

93: Muzambi R, Bhaskaran K, Rentsch CT, Smeeth L, Brayne C, Garfield V, Williams
DM, Chaturvedi N, Warren-Gash C. Are infections associated with cognitive
decline and neuroimaging outcomes? A historical cohort study using data from the
UK Biobank study linked to electronic health records. Transl Psychiatry. 2022
Sep 15;12(1):385. doi: 10.1038/s41398-022-02145-z. PMID: 36109502; PMCID:
PMC9478085.

94: Chino B, Cuesta P, Pacios J, de Frutos-Lucas J, Torres-Simón L, Doval S,
Marcos A, Bruña R, Maestú F. Episodic memory dysfunction and hypersynchrony in
brain functional networks in cognitively intact subjects and MCI: a study of 379
individuals. Geroscience. 2022 Sep 15. doi: 10.1007/s11357-022-00656-7. Epub
ahead of print. PMID: 36109436.

95: Varlow C, Vasdev N. Evaluation of Tau Radiotracers in Chronic Traumatic
Encephalopathy. J Nucl Med. 2022 Sep 15:jnumed.122.264404. doi:
10.2967/jnumed.122.264404. Epub ahead of print. PMID: 36109185.

96: Jeong A, Auger SA, Maity S, Fredriksen K, Zhong R, Li L, Distefano MD. <i>In
Vivo</i> Prenylomic Profiling in the Brain of a Transgenic Mouse Model of
Alzheimer's Disease Reveals Increased Prenylation of a Key Set of Proteins. ACS
Chem Biol. 2022 Sep 15. doi: 10.1021/acschembio.2c00486. Epub ahead of print.
PMID: 36109170.

97: Newby D, Linden AB, Fernandes M, Molero Y, Winchester L, Sproviero W, Ghose
U, Li QS, Launer LJ, Duijn CMV, Nevado-Holgado AJ. Comparative effect of
metformin versus sulfonylureas with dementia and Parkinson's disease risk in US
patients over 50 with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2022
Sep;10(5):e003036. doi: 10.1136/bmjdrc-2022-003036. PMID: 36109050; PMCID:
PMC9478804.

98: Frank N, Nugent J, Shire BR, Pickford HD, Rabe P, Sterling AJ, Zarganes-
Tzitzikas T, Grimes T, Thompson AL, Smith RC, Schofield CJ, Brennan PE, Duarte
F, Anderson EA. Synthesis of meta-substituted arene bioisosteres from
[3.1.1]propellane. Nature. 2022 Sep 15. doi: 10.1038/s41586-022-05290-z. Epub
ahead of print. PMID: 36108675.

99: Sang D, Shu T, Pantoja CF, Ibáñez de Opakua A, Zweckstetter M, Holt LJ.
Condensed-phase signaling can expand kinase specificity and respond to
macromolecular crowding. Mol Cell. 2022 Sep 9:S1097-2765(22)00805-X. doi:
10.1016/j.molcel.2022.08.016. Epub ahead of print. PMID: 36108633.

100: Yousof Ali M, Zaib S, Jannat S, Khan I. Discovery of potent and selective
dual cholinesterases and β-secretase inhibitors in pomegranate as a treatment
for Alzheimer's disease. Bioorg Chem. 2022 Sep 10;129:106137. doi:
10.1016/j.bioorg.2022.106137. Epub ahead of print. PMID: 36108590.

101: Xu QQ, Su ZR, Hu Z, Yang W, Xian YF, Lin ZX. Patchouli alcohol ameliorates
the learning and memory impairments in an animal model of Alzheimer's disease
via modulating SIRT1. Phytomedicine. 2022 Nov;106:154441. doi:
10.1016/j.phymed.2022.154441. Epub 2022 Sep 6. PMID: 36108371.

102: Jin J, Arbez N, Sahn JJ, Lu Y, Linkens KT, Hodges TR, Tang A, Wiseman R,
Martin SF, Ross CA. Neuroprotective Effects of σ<sub>2</sub>R/TMEM97 Receptor
Modulators in the Neuronal Model of Huntington's Disease. ACS Chem Neurosci.
2022 Sep 15. doi: 10.1021/acschemneuro.2c00274. Epub ahead of print. PMID:
36108101.

103: Wei Y, Heun-Johnson H, Tysinger B. Using dynamic microsimulation to project
cognitive function in the elderly population. PLoS One. 2022 Sep
15;17(9):e0274417. doi: 10.1371/journal.pone.0274417. PMID: 36107946; PMCID:
PMC9477290.

104: Sun J, Ludvigsson JF, Ingre C, Piehl F, Wirdefeldt K, Zagai U, Ye W, Fang
F. Hospital-treated infections in early- and mid-life and risk of Alzheimer's
disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide
nested case-control study in Sweden. PLoS Med. 2022 Sep 15;19(9):e1004092. doi:
10.1371/journal.pmed.1004092. PMID: 36107840; PMCID: PMC9477309.

105: Webber TA, Kiselica AM, Mikula C, Woods SP. Dispersion-based cognitive
intra-individual variability in dementia with Lewy bodies. Neuropsychology. 2022
Sep 15. doi: 10.1037/neu0000856. Epub ahead of print. PMID: 36107707.

106: Morano NC, Smith RS, Danelon V, Schreiner R, Patel U, Herrera NG, Smith C,
Olson SM, Laerke MK, Celikgil A, Garforth SJ, Garrett-Thomson SC, Lee FS,
Hempstead BL, Almo SC. Human immunomodulatory ligand B7-1 mediates synaptic
remodeling via the p75 neurotrophin receptor. J Clin Invest. 2022 Sep
15:e157002. doi: 10.1172/JCI157002. Epub ahead of print. PMID: 36107635.

107: Wiatrak B, Mieszała P, Gąsiorowski K. Impact of NMDA receptor activation on
DNA damage in PC12 neuron-like cell cultures in the presence of β-amyloid
peptides. Mol Biol Rep. 2022 Sep 15. doi: 10.1007/s11033-022-07856-6. Epub ahead
of print. PMID: 36107376.

108: Koca-Ünsal RB, Şehirli AÖ, Sayıner S, Aksoy U. Relationship of NLRP3
inflammasome with periodontal, endodontic and related systemic diseases. Mol
Biol Rep. 2022 Sep 15. doi: 10.1007/s11033-022-07894-0. Epub ahead of print.
PMID: 36107371.

109: Wang Y, Li T, Li N, Huang C, Xiong X, Xie X, Wu M, Wang L, Jiang J.
6-O-desulfated heparin attenuates myocardial ischemia/reperfusion injury in mice
through the regulation of miR-199a-5p/klotho axis. Glycoconj J. 2022 Sep 15.
doi: 10.1007/s10719-022-10081-9. Epub ahead of print. PMID: 36107266.

110: Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, Wang X, Li L, Liu CC,
Chen K, Zhu Y, Ikezu TC, Li Z, Meneses AD, Jin Y, Knight JA, Chen Y, Bastea L,
Linares C, Sonustun B, Job L, Smith ML, Xie M, Liu YU, Umpierre AD, Haruwaka K,
Quicksall ZS, Storz P, Asmann YW, Wu LJ, Bu G. Elevating microglia TREM2 reduces
amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022 Dec
5;219(12):e20212479. doi: 10.1084/jem.20212479. Epub 2022 Sep 15. PMID:
36107206; PMCID: PMC9481739.

111: Spartano NL, Wang R, Yang Q, Chernofsky A, Murabito JM, Vasan RS, Levy D,
Beiser AS, Seshadri S. Association of Accelerometer-measured Physical Activity
and Sedentary Time with Epigenetic Markers of Aging. Med Sci Sports Exerc. 2022
Sep 13. doi: 10.1249/MSS.0000000000003041. Epub ahead of print. PMID: 36107108.

112: Denesyuk AI, Permyakov SE, Permyakov EA, Johnson MS, Denessiouk K, Uversky
VN. Canonical structural-binding modes in the calmodulin-target protein
complexes. J Biomol Struct Dyn. 2022 Sep 15:1-13. doi:
10.1080/07391102.2022.2123391. Epub ahead of print. PMID: 36106955.

113: Goyal A, Verma A, Dubey N, Raghav J, Agrawal A. Naringenin: A prospective
therapeutic agent for Alzheimer's and Parkinson's disease. J Food Biochem. 2022
Sep 15:e14415. doi: 10.1111/jfbc.14415. Epub ahead of print. PMID: 36106706.

114: John A, Saunders R, Desai R, Bell G, Fearn C, Buckman JEJ, Brown B, Nurock
S, Michael S, Ware P, Marchant NL, Aguirre E, Rio M, Cooper C, Pilling S,
Richards M, Stott J. Associations between psychological therapy outcomes for
depression and incidence of dementia. Psychol Med. 2022 Sep 15:1-11. doi:
10.1017/S0033291722002537. Epub ahead of print. PMID: 36106698.

115: Finneran D, Li Q, Subbarayan MS, Joly-Amado A, Kamath S, Dengler DG, Gordon
MN, Jackson MR, Morgan D, Bickford PC, Smith LH, Nash KR. Concentration and
proteolysis of CX3CL1 may regulate the microglial response to CX3CL1. Glia. 2022
Sep 15. doi: 10.1002/glia.24269. Epub ahead of print. PMID: 36106533.

116: Herzog NJ, Magoulas GD. Convolutional Neural Networks-Based Framework for
Early Identification of Dementia Using MRI of Brain Asymmetry. Int J Neural
Syst. 2022 Sep 15:2250053. doi: 10.1142/S0129065722500538. Epub ahead of print.
PMID: 36106446.

117: Javed MA, Bibi S, Jan MS, Ikram M, Zaidi A, Farooq U, Sadiq A, Rashid U.
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine
oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's
disease: synthesis, pharmacology, toxicity and docking studies. RSC Adv. 2022
Aug 11;12(35):22503-22517. doi: 10.1039/d2ra04183a. PMID: 36105972; PMCID:
PMC9366597.

118: Tao Q, Akhter-Khan SC, Ang TFA, DeCarli C, Alosco ML, Mez J, Killiany R,
Devine S, Rokach A, Itchapurapu IS, Zhang X, Lunetta KL, Steffens DC, Farrer LA,
Greve DN, Au R, Qiu WQ. Different loneliness types, cognitive function, and
brain structure in midlife: Findings from the Framingham Heart Study.
EClinicalMedicine. 2022 Sep 6;53:101643. doi: 10.1016/j.eclinm.2022.101643.
PMID: 36105871; PMCID: PMC9465265.

119: Shen F, Regmi D, Islam M, Raja Somu D, Merk V, Du D. Effects of zinc and
carnosine on aggregation kinetics of Amyloid-β40 peptide. Biochem Biophys Rep.
2022 Sep 6;32:101333. doi: 10.1016/j.bbrep.2022.101333. PMID: 36105613; PMCID:
PMC9464885.

120: Islam F, Shohag S, Akhter S, Islam MR, Sultana S, Mitra S, Chandran D,
Khandaker MU, Ashraf GM, Idris AM, Emran TB, Cavalu S. Exposure of metal
toxicity in Alzheimer's disease: An extensive review. Front Pharmacol. 2022 Aug
29;13:903099. doi: 10.3389/fphar.2022.903099. PMID: 36105221; PMCID: PMC9465172.

121: Guo Y, Qu Y, Li W, Shen H, Cui J, Liu J, Li J, Wu D. Protective effect of
<i>Monarda didymaL.</i> essential oil and its main component thymol on learning
and memory impairment in aging mice. Front Pharmacol. 2022 Aug 29;13:992269.
doi: 10.3389/fphar.2022.992269. PMID: 36105199; PMCID: PMC9464920.

122: Liu Y, Zhang X, Lin W, Kehriman N, Kuang W, Ling X. Multi-factor combined
biomarker screening strategy to rapidly diagnose Alzheimer's disease and
evaluate drug effect based on a rat model. J Pharm Anal. 2022 Aug;12(4):627-636.
doi: 10.1016/j.jpha.2022.04.003. Epub 2022 Apr 19. PMID: 36105160; PMCID:
PMC9463486.

123: Zhang Y, Guo K, Zhang P, Zhang M, Li X, Zhou S, Sun H, Wang W, Wang H, Hu
Y. Exploring the mechanism of YangXue QingNao Wan based on network pharmacology
in the treatment of Alzheimer's disease. Front Genet. 2022 Aug 29;13:942203.
doi: 10.3389/fgene.2022.942203. PMID: 36105078; PMCID: PMC9465410.

124: Wang Y, Zhang H, Hua L, Wang Z, Geng S, Zhang H, Zeng Z, Zhao J, Wang X,
Wang Y. Curcumin prevents Alzheimer's disease progression by upregulating JMJD3.
Am J Transl Res. 2022 Aug 15;14(8):5280-5294. PMID: 36105064; PMCID: PMC9452350.

125: Hao X, Li Y, Huang G, Zeng Y. Role of the N6-methyladenosine regulatory
factor in reducing the risk of cardiovascular disease: subtype diagnosis
following aerobic exercise-assisted weight loss. Am J Transl Res. 2022 Aug
15;14(8):5363-5378. PMID: 36105062; PMCID: PMC9452351.

126: da Costa DC, Teixeira HRC, Silva RC, Francischini IAG, de Paula da Silva
CHT, da Silva Hage-Melim LI. <i>In silico</i> Study of Acetylcholinesterase and
Beta-secretase Inhibitors: Potential Multitarget Anti-Alzheimer's Agents. Cent
Nerv Syst Agents Med Chem. 2022;22(2):139-150. doi:
10.2174/1871524922666220517110606. PMID: 36104859.

127: Xue J, Yao R, Cui X, Wang B, Wei J, Wu X, Sun J, Yang Y, Xiang J, Liu Y.
Abnormal information interaction in multilayer directed network based on cross-
frequency integration of mild cognitive impairment and Alzheimer's disease.
Cereb Cortex. 2022 Sep 14:bhac339. doi: 10.1093/cercor/bhac339. Epub ahead of
print. PMID: 36104855.

128: Sakr FA, Grothe MJ, Cavedo E, Jelistratova I, Habert MO, Dyrba M, Gonzalez-
Escamilla G, Bertin H, Locatelli M, Lehericy S, Teipel S, Dubois B, Hampel H;
INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI).
Correction: Applicability of in vivo staging of regional amyloid burden in a
cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD
study. Alzheimers Res Ther. 2022 Sep 14;14(1):131. doi:
10.1186/s13195-022-01025-4. Erratum for: Alzheimers Res Ther. 2019 Jan
31;11(1):15. PMID: 36104713; PMCID: PMC9472399.

129: Shang Y, Sun X, Chen X, Wang Q, Wang EJ, Miller E, Xu R, Pieper AA, Qi X. A
CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer's
disease. Acta Neuropathol. 2022 Sep 14. doi: 10.1007/s00401-022-02499-0. Epub
ahead of print. PMID: 36104602.

130: Khamse S, Alizadeh S, Bernhart SH, Afshar H, Delbari A, Ohadi M. A (GCC)
repeat in SBF1 reveals a novel biological phenomenon in human and links to late
onset neurocognitive disorder. Sci Rep. 2022 Sep 14;12(1):15480. doi:
10.1038/s41598-022-19878-y. PMID: 36104480; PMCID: PMC9474449.

131: Nguyen TD, Watanabe A, Burleigh S, Ghaffarzadegan T, Kanklai J, Prykhodko
O, Hållenius FF, Nyman M. Monobutyrin and monovalerin improve gut-blood-brain
biomarkers and alter gut microbiota composition in high-fat fed apolipoprotein-
E-knockout rats. Sci Rep. 2022 Sep 14;12(1):15454. doi:
10.1038/s41598-022-19502-z. PMID: 36104381; PMCID: PMC9475028.

132: Bigi A, Cascella R, Chiti F, Cecchi C. Amyloid fibrils act as a reservoir
of soluble oligomers, the main culprits in protein deposition diseases.
Bioessays. 2022 Sep 14:e2200086. doi: 10.1002/bies.202200086. Epub ahead of
print. PMID: 36104212.

133: Shimokawa H, Shindo T, Ishiki A, Tomita N, Ichijyo S, Watanabe T, Nakata T,
Eguchi K, Kikuchi Y, Shiroto T, Takahashi J, Yasuda S, Arai H. A Pilot Study of
Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of
Alzheimer's Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled
Trial. Tohoku J Exp Med. 2022 Sep 15. doi: 10.1620/tjem.2022.J078. Epub ahead of
print. PMID: 36104179.

134: Amasi-Hartoonian N, Pariante CM, Cattaneo A, Sforzini L. Understanding
treatment-resistant depression using "omics" techniques: A systematic review. J
Affect Disord. 2022 Dec 1;318:423-455. doi: 10.1016/j.jad.2022.09.011. Epub 2022
Sep 11. PMID: 36103934.

135: Wallesch CW. Down-Syndrom und Alzheimer-Demenz [Down Syndrome and Alzheimer
Dementia]. Fortschr Neurol Psychiatr. 2022 Sep;90(9):394-395. German. doi:
10.1055/a-1895-6817. Epub 2022 Sep 14. PMID: 36103896.

136: Furman M, Fleitas-Rumak P, Lopez-Segura P, Furman M, Tafet G, de Erausquin
GA, Ortiz T. Cortical activity involved in perception and imagery of visual
stimuli in a subject with aphantasia. An EEG case report. Neurocase. 2022 Sep
14:1-12. doi: 10.1080/13554794.2022.2122848. Epub ahead of print. PMID:
36103716.

137: Boutilier JJ, Loganathar P, Linden A, Scheer E, Noejovich S, Elliott C,
Zuraw M, Werner NE. Correction: A Web-Based Platform (CareVirtue) to Support
Caregivers of People Living With Alzheimer Disease and Related Dementias: Mixed
Methods Feasibility Study. JMIR Aging. 2022 Sep 14;5(3):e41912. doi:
10.2196/41912. Erratum for: https://aging.jmir.org/2022/3/e36975. PMID:
36103711; PMCID: PMC9520396.

138: Yoshida N, Kageyama H, Akai H, Yasaka K, Sugawara H, Okada Y, Kunimatsu A.
Motion correction in MR image for analysis of VSRAD using generative adversarial
network. PLoS One. 2022 Sep 14;17(9):e0274576. doi:
10.1371/journal.pone.0274576. PMID: 36103561; PMCID: PMC9473426.

139: Malotaux V, Dricot L, Quenon L, Lhommel R, Ivanoiu A, Hanseeuw B. Default-
mode network connectivity changes during the progression towards Alzheimer's
dementia: A longitudinal functional MRI study. Brain Connect. 2022 Sep 14. doi:
10.1089/brain.2022.0008. Epub ahead of print. PMID: 36103377.

140: Shaw LM, Vanderstichele H, Knapik-Czajka M, Blennow K, Trojanowski JQ.
Establishing an Autopsy-Based Cerebrospinal Fluid Biomarker Signature in
Alzheimer Disease Patients. Clin Chem. 2022 Aug 30:hvac137. doi:
10.1093/clinchem/hvac137. Epub ahead of print. PMID: 36103266.

141: Therriault J, Gauthier S, Rosa-Neto P. <i>In vivo</i> tau staging in
Alzheimer's disease. Aging (Albany NY). 2022 Sep 14;14(17):6842-6843. doi:
10.18632/aging.204293. Epub 2022 Sep 14. PMID: 36103250; PMCID: PMC9512513.

142: McCaughey D, McGhan G, Flemons K, Hindmarch W, Brundrit K. Public Health
Messaging during the COVID-19 Pandemic and Its Impact on Family Caregivers'
COVID-19 Knowledge. Healthc Policy. 2022 Aug;18(1):75-89. doi:
10.12927/hcpol.2022.26903. PMID: 36103239; PMCID: PMC9467267.

143: Gregory S, Blennow K, Homer NZM, Ritchie CW, Muniz-Terrera G. Self-reported
diabetes is associated with allocentric spatial processing in the European
Prevention of Alzheimer's Dementia Longitudinal Cohort Study. Eur J Neurosci.
2022 Sep 14. doi: 10.1111/ejn.15821. Epub ahead of print. PMID: 36103146.

144: Simrén J, Weninger H, Brum WS, Khalil S, Benedet AL, Blennow K, Zetterberg
H, Ashton NJ. Differences between blood and cerebrospinal fluid glial fibrillary
Acidic protein levels: The effect of sample stability. Alzheimers Dement. 2022
Sep 14. doi: 10.1002/alz.12806. Epub ahead of print. PMID: 36102852.

145: Wagen AZ, Coath W, Keshavan A, James SN, Parker TD, Lane CA, Buchanan SM,
Keuss SE, Storey M, Lu K, Macdougall A, Murray-Smith H, Freiberger T, Cash DM,
Malone IB, Barnes J, Sudre CH, Wong A, Pavisic IM, Street R, Crutch SJ, Escott-
Price V, Leonenko G, Zetterberg H, Wellington H, Heslegrave A, Barkhof F,
Richards M, Fox NC, Cole JH, Schott JM. Life course, genetic, and
neuropathological associations with brain age in the 1946 British Birth Cohort:
a population-based study. Lancet Healthy Longev. 2022 Sep;3(9):e607-e616. doi:
10.1016/S2666-7568(22)00167-2. Epub 2022 Aug 22. PMID: 36102775.

146: Adkins-Jackson PB, Belsky DW. Alzheimer's disease risk biomarkers: progress
and challenges. Lancet Healthy Longev. 2022 Sep;3(9):e575-e576. doi:
10.1016/S2666-7568(22)00191-X. Epub 2022 Aug 22. PMID: 36102768.

147: Qu YJ, Ding MR, Gu C, Zhang LM, Zhen RR, Chen JF, Hu B, An HM. Acteoside
and ursolic acid synergistically protects H<sub>2</sub>O<sub>2</sub>-induced
neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to
experimental validation. Pharm Biol. 2022 Dec;60(1):1751-1761. doi:
10.1080/13880209.2022.2098344. PMID: 36102631; PMCID: PMC9487927.

148: Bernier PJ, Gourdeau C, Carmichael PH, Beauchemin JP, Voyer P, Hudon C,
Laforce R Jr. It's all about cognitive trajectory: accuracy of the cognitive
charts-MoCA in normal aging, MCI, and dementia. J Am Geriatr Soc. 2022 Sep 14.
doi: 10.1111/jgs.18029. Epub ahead of print. PMID: 36102601.

149: Wong JA, Min DK, Kranick J, Ushasri H, Trinh-Shevrin C, Kwon SC. Exploring
community knowledge, attitudes and perceptions of Alzheimer's
Disease/Alzheimer's Disease-Related Dementias and healthy ageing in Asian
American, Native Hawaiian and Pacific Islanders. Health Soc Care Community. 2022
Sep 14. doi: 10.1111/hsc.14025. Epub ahead of print. PMID: 36102595.

150: Baker LD, Manson JE, Rapp SR, Sesso HD, Gaussoin SA, Shumaker SA, Espeland
MA. Effects of cocoa extract and a multivitamin on cognitive function: A
randomized clinical trial. Alzheimers Dement. 2022 Sep 14. doi:
10.1002/alz.12767. Epub ahead of print. PMID: 36102337.

151: Michno W, Koutarapu S, Camacho R, Toomey C, Stringer K, Minta K, Ge J, Jha
D, Fernandez-Rodriguez J, Brinkmalm G, Zetterberg H, Blennow K, Ryan NS, Lashley
T, Hanrieder J. Chemical traits of cerebral amyloid angiopathy in familial
British-, Danish-, and non-Alzheimer's dementias. J Neurochem. 2022 Sep 14. doi:
10.1111/jnc.15694. Epub ahead of print. PMID: 36102248.

152: Cao LX, Hu WZ, Dong W, Yang Q, Yin JH, Wang Y, Ni X, Huang Y.
Neuropathological report of propionic acidemia. Neuropathology. 2022 Sep 14.
doi: 10.1111/neup.12861. Epub ahead of print. PMID: 36102083.

153: McGinley LM, Chen KS, Mason SN, Rigan DM, Kwentus JF, Hayes JM, Glass ED,
Reynolds EL, Murphy GG, Feldman EL. Monoclonal antibody-mediated
immunosuppression enables long-term survival of transplanted human neural stem
cells in mouse brain. Clin Transl Med. 2022 Sep;12(9):e1046. doi:
10.1002/ctm2.1046. PMID: 36101963; PMCID: PMC9471059.

154: Redwan EM, Aljadawi AA, Uversky VN. Hepatitis C Virus Infection and
Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors.
Biology (Basel). 2022 Jul 21;11(7):1091. doi: 10.3390/biology11071091. PMID:
36101469; PMCID: PMC9312352.

155: Kazemi T, Moodi M, Rajabi S, Sharifi F, Samarghandian S, Khorashadizadeh M,
Farkhondeh T. Trace element concentration and cognitive dysfunction in elderly
residents in Birjand. Curr Alzheimer Res. 2022 Sep 13. doi:
10.2174/1567205019666220913114154. Epub ahead of print. PMID: 36100996.

156: Zhang F, Hu W, Liu Y. GCMM: graph convolution network based on multimodal
attention mechanism for drug repurposing. BMC Bioinformatics. 2022 Sep
13;23(1):372. doi: 10.1186/s12859-022-04911-8. PMID: 36100897; PMCID:
PMC9469552.

157: Zhang YR, Yang L, Wang HF, Wu BS, Huang SY, Cheng W, Feng JF, Yu JT.
Immune-mediated diseases are associated with a higher incidence of dementia: a
prospective cohort study of 375,894 individuals. Alzheimers Res Ther. 2022 Sep
13;14(1):130. doi: 10.1186/s13195-022-01072-x. PMID: 36100869; PMCID:
PMC9472428.

158: Saha P, Sarkar D. Characterization and Classification of ADHD Subtypes: An
Approach Based on the Nodal Distribution of Eigenvector Centrality and
Classification Tree Model. Child Psychiatry Hum Dev. 2022 Sep 13. doi:
10.1007/s10578-022-01432-6. Epub ahead of print. PMID: 36100839.

159: Singh S, Hema, Sharma N, Sachdeva M, Behl T, Zahoor I, Fuloria NK, Sekar M,
Fuloria S, Subramaniyan V, Alsubayiel AM, Dailah HG, Naved T, Bhatia S, Al-
Harrasi A, Aleya L. Focusing the pivotal role of nanotechnology in Huntington's
disease: an insight into the recent advancements. Environ Sci Pollut Res Int.
2022 Sep 14. doi: 10.1007/s11356-022-22830-2. Epub ahead of print. PMID:
36100788.

160: Milà-Alomà M, Ashton NJ, Shekari M, Salvadó G, Ortiz-Romero P, Montoliu-
Gaya L, Benedet AL, Karikari TK, Lantero-Rodriguez J, Vanmechelen E, Day TA,
González-Escalante A, Sánchez-Benavides G, Minguillon C, Fauria K, Molinuevo JL,
Dage JL, Zetterberg H, Gispert JD, Suárez-Calvet M, Blennow K. Publisher
Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology
in preclinical Alzheimer's disease. Nat Med. 2022 Sep;28(9):1965. doi:
10.1038/s41591-022-02037-1. Erratum for: Nat Med. 2022 Sep;28(9):1797-1801.
PMID: 36100683; PMCID: PMC9499861.

161: Vanin AP, Tamagno WA, Alves C, Mesacasa L, Santin LF, Sutorillo NT, Bilibio
D, Müller C, Galon L, Kaizer RR. Neuroprotective potential of Cannabis sativa-
based oils in Caenorhabditis elegans. Sci Rep. 2022 Sep 13;12(1):15376. doi:
10.1038/s41598-022-19598-3. PMID: 36100636; PMCID: PMC9470673.

162: Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P,
Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K,
Ruokolainen J, Kamal MA, Ojha S, Jha NK. CRISPR/Cas9 gene editing: New hope for
Alzheimer's disease therapeutics. J Adv Res. 2022 Sep;40:207-221. doi:
10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. PMID: 36100328; PMCID: PMC9481950.

163: Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and Pathogenesis of
Parkinson's Syndrome. Annu Rev Pathol. 2022 Sep 13. doi: 10.1146/annurev-
pathmechdis-031521-034145. Epub ahead of print. PMID: 36100231.

164: Pallier PN, Ferrara M, Romagnolo F, Ferretti MT, Soreq H, Cerase A.
Chromosomal and environmental contributions to sex differences in the
vulnerability to neurological and neuropsychiatric disorders: Implications for
therapeutic interventions. Prog Neurobiol. 2022 Sep 12;219:102353. doi:
10.1016/j.pneurobio.2022.102353. Epub ahead of print. PMID: 36100191.

165: Sewell KR, Rainey-Smith SR, Villemagne VL, Peiffer J, Sohrabi HR, Taddei K,
Ames D, Doré V, Maruff P, Laws SM, Masters CL, Rowe CC, Martins RN, Erickson KI,
Brown BM. The interaction between physical activity and sleep on cognitive
function and brain beta-amyloid in older adults. Behav Brain Res. 2022 Sep
11;437:114108. doi: 10.1016/j.bbr.2022.114108. Epub ahead of print. PMID:
36100010.

166: Andersen OM, Bøgh N, Landau AM, Pløen GG, Jensen AMG, Monti G, Ulhøi BP,
Nyengaard JR, Jacobsen KR, Jørgensen MM, Holm IE, Kristensen ML, Alstrup AKO,
Hansen ESS, Teunissen CE, Breidenbach L, Droescher M, Liu Y, Pedersen HS,
Callesen H, Luo Y, Bolund L, Brooks DJ, Laustsen C, Small SA, Mikkelsen LF,
Sørensen CB. A genetically modified minipig model for Alzheimer's disease with
SORL1 haploinsufficiency. Cell Rep Med. 2022 Sep 20;3(9):100740. doi:
10.1016/j.xcrm.2022.100740. Epub 2022 Sep 12. PMID: 36099918; PMCID: PMC9512670.

167: Congdon EE, Pan R, Jiang Y, Sandusky-Beltran LA, Dodge A, Lin Y, Liu M, Kuo
MH, Kong XP, Sigurdsson EM. Single domain antibodies targeting pathological tau
protein: Influence of four IgG subclasses on efficacy and toxicity.
EBioMedicine. 2022 Sep 10;84:104249. doi: 10.1016/j.ebiom.2022.104249. Epub
ahead of print. PMID: 36099813; PMCID: PMC9475275.

168: Mustafa AI, Corey-Bloom J, Howell S, Gilbert PE, Goble DJ. Differences in
body sway can be identified in Huntington's disease using a practical balance
assessment device. Parkinsonism Relat Disord. 2022 Mar 14;103:115-118. doi:
10.1016/j.parkreldis.2022.02.024. Epub ahead of print. PMID: 36099752.

169: Smith JR, Gibbons LE, Crane PK, Mungas DM, Glymour MM, Manly JJ, Zahodne
LB, Mayeda ER, Jones RN, Gross AL. Shifting of Cognitive Assessments Between
Face-to-Face and Telephone Administration: Measurement Considerations. J
Gerontol B Psychol Sci Soc Sci. 2022 Sep 13:gbac135. doi:
10.1093/geronb/gbac135. Epub ahead of print. PMID: 36099407.

170: Wong W. Pathogenic putrescine. Sci Signal. 2022 Sep 13;15(751):eade8161.
doi: 10.1126/scisignal.ade8161. Epub 2022 Sep 13. PMID: 36099340.

171: Li J, Wang S, Nicholas LH. Management of Financial Assets by Older Adults
With and Without Dementia or Other Cognitive Impairments. JAMA Netw Open. 2022
Sep 1;5(9):e2231436. doi: 10.1001/jamanetworkopen.2022.31436. PMID: 36098970.

172: Parra MA, Orellana P, Leon T, Victoria CG, Henriquez F, Gomez R, Avalos C,
Damian A, Slachevsky A, Ibañez A, Zetterberg H, Tijms BM, Yokoyama JS, Piña-
Escudero SD, Cochran JN, Matallana DL, Acosta D, Allegri R, Arias-Suárez BP,
Barra B, Behrens MI, Brucki SMD, Busatto G, Caramelli P, Castro-Suarez S,
Contreras V, Custodio N, Dansilio S, la Cruz-Puebla M, de Souza LC, Diaz MM,
Duque L, Farías GA, Ferreira ST, Guimet NM, Kmaid A, Lira D, Lopera F, Meza BM,
Miotto EC, Nitrini R, Nuñez A, O'Neill S, Ochoa J, Pintado-Caipa M, Resende EPF,
Risacher S, Rojas LA, Sabaj V, Schilling L, Sellek AF, Sosa A, Takada LT,
Teixeira AL, Unaucho-Pilalumbo M, Duran-Aniotz C. Biomarkers for dementia in
Latin American countries: Gaps and opportunities. Alzheimers Dement. 2022 Sep
13. doi: 10.1002/alz.12757. Epub ahead of print. PMID: 36098676.

173: Choinski M, Szelag E, Wolak T, Szymaszek A. Neuropsychological correlates
of P300 parameters in individuals with aphasia. Int J Lang Commun Disord. 2022
Sep 13. doi: 10.1111/1460-6984.12781. Epub ahead of print. PMID: 36098626.

174: Tampi RR. Paired associative stimulation (PAS) and Alzheimer's disease
(AD). Int Psychogeriatr. 2022 Sep 13:1-7. doi: 10.1017/S1041610222000813. Epub
ahead of print. PMID: 36098440.

175: Rikkert MGMO, Peeters GMEEG. The multicausality of declines in wellbeing
and cognition in older adults with multimorbidity. Lancet Healthy Longev. 2021
Nov;2(11):e681-e682. doi: 10.1016/S2666-7568(21)00254-3. Epub 2021 Oct 22. PMID:
36098023.

176: Iwagami M, Qizilbash N, Gregson J, Douglas I, Johnson M, Pearce N, Evans S,
Pocock S. Blood cholesterol and risk of dementia in more than 1·8 million people
over two decades: a retrospective cohort study. Lancet Healthy Longev. 2021
Aug;2(8):e498-e506. doi: 10.1016/S2666-7568(21)00150-1. Epub 2021 Jul 23. PMID:
36097999.

177: Liang CS, Li DJ, Yang FC, Tseng PT, Carvalho AF, Stubbs B, Thompson T,
Mueller C, Shin JI, Radua J, Stewart R, Rajji TK, Tu YK, Chen TY, Yeh TC, Tsai
CK, Yu CL, Pan CC, Chu CS. Mortality rates in Alzheimer's disease and non-
Alzheimer's dementias: a systematic review and meta-analysis. Lancet Healthy
Longev. 2021 Aug;2(8):e479-e488. doi: 10.1016/S2666-7568(21)00140-9. Epub 2021
Jul 21. PMID: 36097997.

178: Ishii M. Midlife dyslipidaemia as a modifiable risk factor for later-life
dementia. Lancet Healthy Longev. 2021 Aug;2(8):e453-e454. doi:
10.1016/S2666-7568(21)00175-6. Epub 2021 Jul 23. PMID: 36097993.

179: Oh GY, Moga DC, Abner EL. Gabapentin utilization among older adults with
different cognitive statuses enrolled in the National Alzheimer's Coordinating
Center (2006-2019). Br J Clin Pharmacol. 2022 Sep 13. doi: 10.1111/bcp.15532.
Epub ahead of print. PMID: 36097795.

180: Wang K, Xu C, Theeke LA, Xiao D, Luo X, Xie C. Linear Mixed Model Analysis
of Polygenic Hazard Score on Verbal Memory Decline in Alzheimer's Disease. Nurs
Res. 2022 Sep 12. doi: 10.1097/NNR.0000000000000623. Epub ahead of print. PMID:
36097266.

181: Aghazadeh N, Beilankouhi EAV, Fakhri F, Gargari MK, Bahari P, Moghadami A,
Khodabandeh Z, Valilo M. Involvement of heat shock proteins and
parkin/α-synuclein axis in Parkinson's disease. Mol Biol Rep. 2022 Sep 12. doi:
10.1007/s11033-022-07900-5. Epub ahead of print. PMID: 36097120.

182: Pekna M, Siqin S, de Pablo Y, Stokowska A, Torinsson Naluai Å, Pekny M.
Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent.
Neurochem Res. 2022 Sep 12. doi: 10.1007/s11064-022-03743-5. Epub ahead of
print. PMID: 36097103.

183: Cho SH, Jang M, Ju H, Kang MJ, Yun JM, Yun JW. Association of late-life
body mass index with the risk of Alzheimer disease: a 10-year nationwide
population-based cohort study. Sci Rep. 2022 Sep 12;12(1):15298. doi:
10.1038/s41598-022-19696-2. PMID: 36097042; PMCID: PMC9468036.

184: Molet-Benhamou L, Giudici KV, de Souto Barreto P, Cantet C, Rolland Y;
MAPT/DSA group. Association between urate-lowering therapies and cognitive
decline in community-dwelling older adults. Sci Rep. 2022 Sep 12;12(1):15299.
doi: 10.1038/s41598-022-17808-6. PMID: 36097005; PMCID: PMC9467991.

185: Park CJ, Seo Y, Choe YS, Jang H, Lee H, Kim JP; Alzheimer’s Disease
Neuroimaging Initiative. Predicting conversion of brain β-amyloid positivity in
amyloid-negative individuals. Alzheimers Res Ther. 2022 Sep 12;14(1):129. doi:
10.1186/s13195-022-01067-8. PMID: 36096822; PMCID: PMC9465850.

186: Truong C, Recto C, Lafont C, Canoui-Poitrine F, Belmin JB, Lafuente-
Lafuente C. Effect of Cholinesterase Inhibitors on Mortality in Patients With
Dementia: A Systematic Review of Randomized and Nonrandomized Trials. Neurology.
2022 Sep 12:10.1212/WNL.0000000000201161. doi: 10.1212/WNL.0000000000201161.
Epub ahead of print. PMID: 36096687.

187: Hicks AJ, Ponsford JL, Spitz G, Dore V, Krishnadas N, Roberts C, Rowe CC.
β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional
Study. Neurology. 2022 Sep 13;99(11):e1131-e1141. doi:
10.1212/WNL.0000000000200857. Epub 2022 Jun 15. PMID: 36096678.

188: Hazan J, Wing M, Liu KY, Reeves S, Howard R. Clinical utility of
cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a
systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022 Sep
12:jnnp-2022-329530. doi: 10.1136/jnnp-2022-329530. Epub ahead of print. PMID:
36096664.

189: Metodieva VV, Smith TK, Gunn-Moore FJ. The mitochondrial enzyme 17βHSD10
modulates ischemic and amyloid-β-induced stress in primary mouse astrocytes.
eNeuro. 2022 Sep 12:ENEURO.0040-22.2022. doi: 10.1523/ENEURO.0040-22.2022. Epub
ahead of print. PMID: 36096650.

190: Rahamtullah, Ahmad A, Mishra R. Polyol and sugar osmolytes stabilize the
molten globule state of α-lactalbumin and inhibit amyloid fibril formation.
Biochim Biophys Acta Proteins Proteom. 2022 Sep 10;1870(11-12):140853. doi:
10.1016/j.bbapap.2022.140853. Epub ahead of print. PMID: 36096464.

191: Chen Z, Wei D, Chen X, Huang Y, Shen Z, He W. RNA sequencing uncover
crucial genes mediating progression of large-artery atherosclerotic and small-
artery occlusion ischemic stroke. Brain Res. 2022 Sep 9;1796:148078. doi:
10.1016/j.brainres.2022.148078. Epub ahead of print. PMID: 36096198.

192: Buscho S, Palacios E, Xia F, Shi S, Li S, Luisi J, Kayed R, Motamedi M,
Zhang W, Liu H. Longitudinal characterization of retinal vasculature alterations
with optical coherence tomography angiography in a mouse model of tauopathy. Exp
Eye Res. 2022 Sep 10;224:109240. doi: 10.1016/j.exer.2022.109240. Epub ahead of
print. PMID: 36096190.

193: Lins Alves LK, Cechinel Filho V, de Souza RLR, Furtado-Alle L. BChE
inhibitors from marine organisms - A review. Chem Biol Interact. 2022 Sep
9;367:110136. doi: 10.1016/j.cbi.2022.110136. Epub ahead of print. PMID:
36096160.

194: Vasilopoulou MA, Gioran A, Theodoropoulou M, Koutsaviti A, Roussis V,
Ioannou E, Chondrogianni N. Healthspan improvement and anti-aggregation effects
induced by a marine-derived structural proteasome activator. Redox Biol. 2022
Oct;56:102462. doi: 10.1016/j.redox.2022.102462. Epub 2022 Sep 2. PMID:
36095970; PMCID: PMC9482115.

195: Yuan C, Zheng L, Zhao Y. Protective effect of 3-n-butylphthalide against
intrastriatal injection of malonic acid-induced neurotoxicity and biochemical
alteration in rats. Biomed Pharmacother. 2022 Sep 12;155:113664. doi:
10.1016/j.biopha.2022.113664. Epub ahead of print. PMID: 36095961.

196: Raval NR, Madsen CA, Shalgunov V, Nasser A, Battisti UM, Beaman EE, Juhl M,
Jørgensen LM, Herth MM, Hansen HD, Plavén-Sigray P, Knudsen GM. Evaluation of
the α-synuclein PET radiotracer (d<sub>3</sub>)-[<sup>11</sup>C]MODAG-001 in
pigs. Nucl Med Biol. 2022 Aug 24;114-115:42-48. doi:
10.1016/j.nucmedbio.2022.08.001. Epub ahead of print. PMID: 36095921.

197: Hendra R, Salib MN, Molinski TF. Spiroisoxazoline Inhibitors of
Acetylcholinesterase from <i>Pseudoceratina verrucosa</i>. Quantitative
Chiroptical Analysis of Configurational Heterogeneity, and Total Synthesis of
(±)-Methyl Purpuroceratate C. J Nat Prod. 2022 Sep 23;85(9):2207-2216. doi:
10.1021/acs.jnatprod.2c00595. Epub 2022 Sep 12. PMID: 36095307.

198: Chikugo A, Irie Y, Tsukano C, Uchino A, Maki T, Kume T, Kawase T, Hirose K,
Kageyama Y, Tooyama I, Irie K. Optimization of the Linker Length in the Dimer
Model of E22P-Aβ40 Tethered at Position 38. ACS Chem Neurosci. 2022 Sep 12. doi:
10.1021/acschemneuro.2c00436. Epub ahead of print. PMID: 36095282.

199: Shirotani K, Hatta D, Wakita N, Watanabe K, Iwata N. The role of TREM2
N-glycans in trafficking to the cell surface and signal transduction of TREM2. J
Biochem. 2022 Sep 12:mvac073. doi: 10.1093/jb/mvac073. Epub ahead of print.
PMID: 36095053.

200: González KA, Stickel AM, Kaur SS, Ramos AR, González HM, Tarraf W. Serum
Cystatin-C is linked to increased prevalence of diabetes and higher risk of
mortality in diverse middle-aged and older adults. PLoS One. 2022 Sep
12;17(9):e0270289. doi: 10.1371/journal.pone.0270289. PMID: 36094936; PMCID:
PMC9467319.